Abstract
INTRODUCTION
Functional graft recovery remains one of the major complications after liver surgery. Cold static preservation is an inherent feature of liver transplantation (LT) and is strongly associated with graft outcome after transplantation [1] . Despite continued attempts to improve preservation solutions, success in liver trans plantation is always hampered by the complexity of ischemia reperfusion (I/R) injury [2, 3] . In addition, exacerbated I/R injury is due, to a large extent, to the quality of the graft and to its conservation in preservation solutions [4, 5] . In the liver, the presence of steatosis makes the graft more vulnerable to cold I/R injury [6] and thus aggravates the detrimental effects of cold I/R injury in fatty liver grafts preserved in commercial solutions. University of Wisconsin (UW) solution is considered to be the standard solution for liver graft preservation. However, alternative preservation solutions have been used in clinical liver transplantation, such as Institut Georges Lopez1 (IGL1), histidinetryptophan ketoglutarate (HTK) and Celsior solutions. Briefly, IGL-1 is a new preservation solution whose differences visà vis UW are the oncotic agent used (PEG35, instead of HES) and its lower potassium and lower viscosity. HTK and Celsior solutions have no oncotic agent [2, 7] . The ubiquitinproteasome system (UPS) is the principal nonlysosomal proteolytic system and is thought to contribute to a large variety of pathologies, including I/R injury associated with LT [810] . Recently, we showed that UPS modulation is a pharmacological target for improving graft preservation and for reducing I/R injury in the liver [10] . Moreover, it is has been well established that proteolysis is necessary to control protein concentra tion and to prevent its abnormal accumulation [8] .
Proteasomes also perform multiple intracellular func tions, such as the degradation of damaged proteins and the modulation of many regulatory proteins that are involved in inflammatory processes including the cell cycle, metabolism, growth and differentiation [8] . In fact, proteolytic activity is necessary for amino acid (AA) recycling of proteins that are no longer needed, thus preventing their accumulation in the cytoplasm [11, 12] . The first evidence that proteolysis has a detrimental effect on liver graft outcome after transplantation was provided by Calmus et al [13] who showed that the degree of proteolytic activity detected by the free amino acids in the effluent of human liver grafts is a good predictive marker for postoperative graft function when using UW solution. Later, Upadhya et al [14] proved that the composition of the preservation solution may be relevant for the prevention of liver proteolysis. These authors demonstrated that lactobionate, a component of the UW solution, is a key factor for preventing the release of matrix metalloproteinases, particularly gelatinases, during cold preservation [15] . More recently, other solutions such as IGL1 have also been considered as potential alternatives to UW [1, 16] . Despite the proven efficiency of IGL1, especially in steatotic liver preservation, its effects on graft proteolysis have not been investigated to date.
It is well known that energy breakdown following oxygen deprivation in liver graft is the main event during cold storage, and that its effects are concomitant with a significant decrease in ATP content which leads to severe graft damage [2] . It was recently reported that this ATP decline may activate a subset of 26S protea somes, a celldestructive protease that contributes to myocardial injury during cold ischemia [17, 18] . Moreover, this proteasome inhibition contributes to prolonging myocardial viability in hypothermic preservation [19] . Recently, we demonstrated that proteasome inhibitors such as MG132 and bortezomib protected fatty liver grafts when they were used as additives to UW and IGL1 solutions [10, 20] . However, the role of the UPS system and liver proteolysis in fatty liver graft preservation has not been fully investigated. The aim of this study is to assess the potential relationship between proteolysis, energy breakdown and liver injury using UW and IGL1 solutions, in order to shed new light on the molecular and cellular mechanisms involved in liver cold I/R injury.
MATERIALS AND METHODS

Animals
Homozygous (obese [Ob]) Zücker rats aged 1618 wk were purchased from IffaCredo (L'Abresle, France). An "ex vivo" perfused rat liver model was used, as previously described. All procedures were performed under isofluorane inhalation anesthesia according to the European Union regulations (Directive 86/609 EEC) for animal experiments [21] .
Preservation solutions
We used UW (gold standard) and IGL1 solutions. IGL1 solution is a modification of UW solution in which hydroxyethyl starch (HES) is substituted by polyethylene glycol 35 (PEG 35) and the ionic K/Na ratio is also reversed.
Experimental groups and isolated perfused liver model
Briefly, 24 rats were randomly divided into three groups. The abdomen was opened by midline incision, following cannulation of the common bile duct, and the portal vein, the splenic and gastroduodenal veins were ligated. After organ recovery the livers were flushed with UW (UW group) and IGL-1 (IGL-1 group) preservation solutions respectively, and then stored in each solution for 24 h at 4 ℃. Next, the preserved livers were flushed with a perfusion liquid consisting of a cell culture medium (William's medium E, Bio Whitaker, Barcelona, Spain), with a KrebsHenseleit like electrolyte composition enriched with 5% albumin as osmotic support. For the reperfusion, livers were connected via the portal vein to a recirculating perfusion system for 2 h at 37 ℃. The third study group was a Control group (Cont) in which livers were flushed and immediately perfused ex vivo without ischemic preservation. Time 0 was the point at which the portal catheter was satisfactorily connected to the circuit. During an initial equilibration period of 15 min of perfusion, the flow was progressively increased in order to stabilize the portal pressure at 12 mmHg (Pression Monitor BP1, Instruments, Inc., Sarasota, FL, United States). In order to maintain the portal pressure at 12 mmHg, the flow rate was modified using a peristaltic pump (Minipuls 3, Gilson, France). The buffer was continuously ventilated with a 95% O2 and 5% CO2 gas mixture. It was subsequently passed through a heat exchanger (37 ℃) and a bubble trap prior to entering the liver [21, 22] . Protocol I Proteasome activity and ATP levels after 24 h cold storage: In order to evaluate the proteasome activity and ATP breakdown in steatotic liver grafts following 24 hcold storage in UW or IGL1, aliquots of the flush effluents and liver tissue samples were collected and stored at 80 ℃ for subsequent measurement. Control livers (Cont 1 group) were flushed with Ringer's lactate solution via the portal vein without ischemic preservation.
Protocol II Evaluation of proteasome activity and liver viability after 2 h reperfusion: To examine the role of UW and IGL1 solutions in proteasome activation and their subsequent effect on proteolysis, liver function and also liver damage, fatty livers were subjected to two hours of normoxic reperfusion. Then, the perfusate effluent and the liver tissue sample were collected and stored at 80 ℃ for later measurement. In control group (Cont 2) livers were flushed with Ringer's lactate and immediately perfused ex vivo without ischemic preservation.
Biochemical determinations
Nucleotide analysis and ATP content: Livers were homogenized in perchloric acid solution, and and a near infrared Titanium:Saphire laser (MaiTai, SpectraPhysics) for twophoton excitation running at 800 nm. Images were acquired with resonant scan at 8000 lines/s. Twophoton excitation was performed at 800 nm and emission of the different fluorescent dyes was captured at the following wavelength ranges: Evans blue dye (515560 nm), and rhodamine 123 (500550 nm) [28, 29] .
Western blotting analysis of PPARγ , HMGB-1, Caspase3, cytochrome C, 20S5beta and 19S proteasome subunit and β -Actin Liver tissue was homogenized as described else where [30] , and proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride membranes. Membranes were immunoblotted with antibodies against 20S5beta and 19S proteasome subunits (BMLPW 8895,and BMLPW8825 respectively, ENZO Life Sciences, Madrid, Spain), PPARγ and HMGB1 (Abcam, United Kingdom), cleaved caspase 3 and cytochrome C (Cell Signaling, Beverly, MA, United States), and βActin (Sigma Chemical, St. Louis, MO, United States). Signals were detected by enhanced chemiluminescence and quantified by scanning densitometry [10] .
Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling method [31] To detect apoptotic cells, 16μmthick frozen sections from livers were collected on polyLlysinecoated glass slides, and the nuclear DNA fragmentation of apoptotic cells was labeled in situ by the TUNEL method using an ApopTag Peroxidase In Situ Apoptosis Detection Kit (Intergen Co. Purchase, NY, United States). Briefly, the sections were fixed in 1% paraformaldehyde in PBS, pH 7.4 for 10 min at room temperature and, after washing in PBS, they were postfixed in precooled ethanol:acetic acid 2:1 for 5 min at 20 ℃. After rinsing in distilled water, the sections were treated with 3% hydrogen peroxide in 10% methanol for 5 min, washed with distilled water and incubated in the equilibration buffer provided for 10 min. Then, the sections were incubated with terminal deoxynucleotide transferase (TdT) in the reaction buffer provided with digoxigenindUTP, in a humidifier chamber at 37 ℃ for 1 h. The incorporated digoxigenindUTP was detected by peroxidaseconjugated antidigoxigenin antibody and the signal developed by incubation with 3,3diaminobenzidine (DAB) in the presence of H2O2. The slides were counterstained with Harris hematoxylin. Negative controls were prepared by replacing the antidigoxigenin antibody with phosphate saline buffer, and a case of breast carcinoma was included as positive control.
Statistical analysis
Data are expressed as means ± SD and were com pared statistically by variance analysis, followed by the the adenine nucleotide pool was measured by high performance liquid chromatography (HPLC) as pre viously reported [23, 24] .
Assessment of liver proteolysis [7] : Free amino acid content in ex vivo eluates and tissue specimens was measured by HPLC techniques, as previously described [25] . Briefly, effluent and tissue homogenization samples were first deproteinized by ultrafiltration and then derivatized with phenylisothiocyanate (PITC) to produce phenylthiocarbamyl (PTC) amino acids. Amino acids were determined by automated gradient reverse phase HPLC and ultraviolet detection at 254 nm. Quantitative analysis of total free amino acids was performed using the PICO.TAG Amino Acid Analysis System [25] .
Transaminase assay: Hepatic injury was evaluated according to transaminase levels using a commercial kit from Boehringer Mannheim (Munich, Germany) [10] .
Proteasome chymotryptic-like activity assay [9, 10] : ATPdependent chymotryptic activity of the proteasome was measured using the substrate NSucLeuLeuVal Tyraminomethylcoumarin (ENZO Life Sciences). The cleavage products AMC were analyzed in a fluorimeter (excitation/emission 380/460 nm). Product formation was linear with time (at least for 60 min). Background activity (caused by nonproteasomal degradation) was determined by the addition of the proteasome inhibitor epoxomicin at a final concentration of 20 μmol/L (ENZO Life Sciences).
Glutamate dehydrogenase activity [10] : Liver mitochondrial damage was measured by GLDH activity levels at the end of reperfusion, as previously reported.
Inflammatory mediators: TNF alpha and IL-1/IL10
TNF alpha levels were measured using a commercial immunoassay kit for rat TNF alpha from Biosource (Caramillo) [10, 26] . IL1 beta and IL10 were measured by enzymelinked immunosorbent assay as previously reported [10, 27] . Commercial kits from Amersham LifeScience (Amersham, United Kingdom) were used. 
Confocal microscopy for mitochondrial damage
RESULTS
We evaluated the relevance of proteasome activity and proteolysis in fatty livers preserved in IGL1 and UW solutions when subjected to normothermic reperfusion. As Figure 1A shows, chymotrypticlike proteasome activity increased in steatotic liver grafts during cold preservation in UW solution compared with control nonpreserved livers. However, steatotic livers preserved in IGL1 solution showed lower chymotrypticlike proteasome activity than those preserved in UW solution. Given the close relationship between proteasome activity and the ATP contents during cold preservation [18] , we next evaluated the ATP concentration during liver preservation. Lower ATP levels during cold storage were observed in steatotic livers preserved in UW solution than in nonpreserved livers. ATP breakdown was more effectively prevented by the use of IGL1 solution ( Figure  1B ).
With these results in mind, we also evaluated the chymotrypticlike proteasome activity and the 19S and 20S proteasome protein levels after reperfusion. As indicated in Figure 2A , the chymotrypticlike proteasome activity after reperfusion follows the same pattern profile as those observed for cold storage. The 20S proteasome protein levels were reduced only when IGL1 preservation solution was used. In contrast, the 19S subset protein levels remained unchanged across all experimental groups ( Figure 2B and C) . Also, the AA profiling studies confirmed that IGL-1 offered more efficient prevention of AA release in tissue graft specimens and effluents after 2 hreperfusion at 37 ℃. The AA profiles obtained in liver tissue ( Figure 3B ) and eluate samples ( Figure 3A) were similar but were seen more in tissue samples than in ex vivo eluates, thus confirming the relevance of proteolysis (measured as free AA release) after cold I/R injury. The better prevention of liver proteolysis in grafts preserved in IGL1 solution than in UW was consistent with significant reductions in other parameters associated with the pathophysiology of liver I/R injury, such as transaminases (ALT and AST) and GLDH release as sensitive and specific markers of mitochondrial damage ( Table 1 ).
Given that proteasome activity plays a crucial role in the modulation of many of the regulatory proteins involved in inflammatory processes in fatty liver grafts [8] , we evaluated the involvement of other inflammatory markers in fatty liver, such as PPARγ, in the proteasome changes and proteolysis inhibition in steatotic liver grafts subjected to cold I/R injury. As shown in Figure 4A , PPARγ protein levels in steatotic liver grafts preserved in UW solution remained unchanged compared with control non preserved grafts, but increased significantly in grafts preserved in IGL1 preservation solution. We also measured the effect of preservation solution on other cytokines such as high mobility group box 1 (HMGB1) which was recently shown to be involved in fatty liver preservation and transplantation [32] . IGL1 showed lower levels of HMGB1 than UW ( Figure 4B ) concomitant with a significant reduction in the release of other in flammatory cytokines such as TNFα but not for IL1. IGL1 also increased the concomitant release of anti inflammatory IL10 in fatty livers after reperfusion (Table 2) . Next, we evaluated the effect of proteasome activity and proteolysis modulation on apoptosis and autophagy induction. Figure 5 shows a significant increase in cytochrome C and cleaved caspase 3 protein levels in steatotic livers preserved in UW solution compared with nonpreserved ones. However, preservation in IGL1 solution significantly reduced both apoptotic markers. In addition, the autophagy related ubiquitinbinding protein SQSTM1/p62, which is involved in aggresome formation and degradation through autophagy, is increased in steatotic livers preserved in UW solution compared with those pre served in IGL1 solution ( Figure 5C ).
This effect on liver apoptosis in both IGL1 and UW solutions was also corroborated by the percentage of TUNELpositive hepatocytes (Figure 6 ). Only a few sinusoidal lining cells were positive to TUNEL staining in control nonpreserved steatotic livers ( Figure  6B ). After preservation with UW and reperfusion, the number of positive cells significantly increased ( Figure 6B ). Preservation with IGL1 reduced apoptotic 
cell death ( Figure 6B ). In all cases, single (but not clustered) TUNELstained cells were observed more extensively in periportal and midzonal areas. Finally, the confocal microscopic study confirmed that steatotic livers preserved in IGL1 solution conserved the membrane potential of liver mitochondria more efficiently, as shown by an increase in the rhodamine 123 cell viability marker (in green) and a decrease in Evans blue labeling (in red), indicating the albumin content and the disrupted mitochondrial membranes ( Figure 6A ).
DISCUSSION
At present, a considerable number of fatty donor livers have to be discarded, a situation that accentuates even further the critical shortage of human donor livers.
A better knowledge of the preservation mechanisms of steatotic liver grafts is urgently needed to reduce their high vulnerability to cold I/R injury, and thus to improve their viability after transplantation [33, 34] . In this study, we investigated the involvement of UPS activation and liver proteolysis and their relationship with the breakdown energy metabolism in steatotic liver grafts preserved in different commercial preservation solutions such as IGL1 and UW. We also associated the changes in UPS activation during cold I/R injury with the inflammatory events and liver apoptosis. Our data demonstrate that IGL1 prevented liver proteolysis more effectively than UW. In all cases, free AA levels determined in tissue specimens and eluates were lower in IGL1 than in UW after cold I/R. This improved prevention of liver proteolysis with IGL1 is consistent with its more effective protection against I/R injury. This could be explained, in part, by the presence of different oncotic agents: PEG35 in IGL1, and HES in UW. In fact, we have recently demonstrated that the addition of PEG35 to washout solution protects the liver against I/R injury by the inhibition of metalloproteinases MMP9 and MMP2, a finding that may explain its role in preventing liver proteolysis [21] . The presence of lactobionate (a common ingredient of the UW and IGL1 solutions) may also help to prevent liver proteolysis due its strong inhibitory effect on gelatinases, presumably via calcium or zinc chelation [13, 14] . This effective pre vention of proteolysis is also consistent with the significant reduction in proteasome activity reflected by decreases in chymotrypticlike proteasome activity and 20S proteasome protein levels and the better prevention of energy metabolism breakdown with IGL1 solution. In fact, a recent report established a functional link between 26S proteasome activity and ATP depletion in tissue during cold I/R injury [18] . Those authors advanced that ATP depletion during ischemic insult appears to activate the 26S proteasome which is formed from a multimeric proteasome core particle (20S proteasome) which is singly or doubly capped at its ends by a 19S regulator complex [17] . Taking this into account, we suggest that the reduced 20S proteasome protein levels in steatotic livers preserved in IGL1 solution are to do some extent the consequence of the better preservation of ATP content in this group, which thus affects 26S assembly and activity. Furthermore, our results are in accordance with previous studies which have demonstrated the relevance of proteasome inhibition in protecting steatotic liver grafts against I/R injury when preservation solutions were supplemented with proteasome inhibitors MG132 and bortezomib [10, 20] . In order to explain the mechanisms by which pro teasome modulation and proteolysis inhibition protect steatotic livers against cold I/R injury, we also assessed levels of PPARγ and HMGB1 proteins, which are both involved in the modulation of the inflammatory response after I/R injury [3537] . It is clear that PPARγ belongs to the hormone nuclear receptor superfamily of ligandactivated transcription factors which are major regulators of postischemic liver injury [35] . Its protective effect is mediated by its anti-inflammatory properties via the inhibition of pro-inflammatory gene expression [35] in which the UPS has recently been implicated; the UPS is responsible for PPAR turnover and is also involved in the modulation of the ligand dependent activity of these nuclear receptors [38] . The fact that the UPS is the major system for selective degradation of shortlived proteins in eukaryotic cells such as PPARγ [38] suggests that proteasome inhibition after steatotic liver graft preservation in IGL1 solution may be responsible for the PPARγ accumulation induced, thus leading to a reduction in the expression of pro-inflammatory proteins [39] . These findings were also confirmed by the lower HMGB-1 protein levels in livers preserved in IGL1 solution than in livers preserved in UW. HMGB1 is a wellknown extracellular signaling pro inflammatory mediator which, when released from cells, leads to cell death in several pathologies including liver I/R [32] . Our results corroborate those of a previous study which demonstrated that PPARγmediated upregulation of miR1423p inhibits HMGB1 expression, which, in turn, is a novel antiinflammatory mechanism of PPARγ and plays an important role in the treatment of inflammatory diseases [40] . Moreover, HMGB1 is associated with apoptotic cell death [41] and autophagy modulation [42, 43] . Next we evaluated both parameters after cold I/R injury in steatotic livers preserved in UW and IGL1 solutions. Our results demonstrated that the use of IGL1 reduced apoptotic cell death, as reflected by decreases in cleaved caspase3 and cytochrome C protein levels when compared with UW solution. The relevance of cytochrome c as a reliable biomarker of mitochondrial damage in fatty liver disease was also reported by another study [44] . These results were correlated with a better prevention of liver mitochondrial damage and were also consistent with the finding that IGL1 solution efficiently prevented liver apoptosis in rat liver transplantation [45] . Finally, in order to explore the effect of proteasome modulation on autophagy, we determined the levels of autophagyrelated ubiquitinbinding protein SQSTM1/p62. This protein is involved in aggresome formation and degradation through autophagy which is associated with the liver graft selfresponse to cold I/R injury (the SQSTM/p62 substrate that accumulates in autophagydeficient cells) [46, 47] . Our results de monstrated that UW solution increased SQSTM1/ p62 protein levels, which are inversely correlated to autophagy, while the use of IGL1 solution reduced SQSTM1/p62 protein levels, thus showing autophagic activation, as a response to better preservation mechanisms. These results corroborate our previous finding that impaired autophagic clearance after steatotic liver preservation is correlated with increased liver injury [31] . In conclusion, we show that liver graft proteolysis and proteasome activation are dependent on the organ preservation solutions used for liver transplantation such as UW and IGL-1. Our results confirm the relevance of both markers for evaluating the graft damage caused by cold I/R injury in fatty liver preservation.
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COMMENTS
Background
Cold ischemia reperfusion (I/R) injury is a multifactorial process that can interfere with graft function after liver transplantation (LT). A better understanding of the pathophysiology of this injury is fundamental for the development of protective strategies able to improve the outcome of LT. The ischemic graft damage that occurs during cold storage of fatty liver grafts depends in part on the ATP-energy breakdown. It is well known that the prevention of ATP-breakdown during cold static preservation is associated with inhibition of ubiquitin-proteasome system (UPS) activity, which helps to protect the liver graft against reperfusion. In this context the selection of commercial organ solution seems crucial for modulating the UPS, as well as the graft proteolysis against cold I/R injury. We demonstrate that Institut Georges Lopez-1 (IGL-1) solution reduces cold I/R injury more efficiently by helping to prevent ATP-breakdown and subsequently achieving a higher UPS inhibition than University of Wisconsin (UW). Both these factors are modulated by the organ preservation solution and determine the degree of proteolysis in the liver graft.
Research frontiers
The authors focused on strategies for interfering with the mechanisms responsible for hepatic I/R injury associated with LT, and on strategies for enhancing the endogenous mechanisms that protect against cold ischemic damage. UW and IGL-1 solutions are widely used in LT. They demonstrate that the nature of the oncotic agent present in UW and IGL-1 solutions is responsible, in part, for the modulation of energy breakdown and its subsequent inhibitory action on the UPS, which are key factors in graft protection against I/ R insult. In the present study IGL-1 showed more hepato-protective effects than UW, due, in part, to the presence of the oncotic agent PEG-35.
Innovations and breakthroughs
This study demonstrates for the first time that UPS inhibition is a key factor in fatty liver preservation using different commercial organ preservation solutions such as UW and IGL-1. UPS inhibition may explain the better prevention of the proteolysis observed in IGL-1 than in UW, thus favoring the use of IGL-1 in fatty liver graft preservation.
Applications
UPS inhibition and the degree of proteolysis can be used to predict the viability of steatotic liver grafts after prolonged static preservation.
Terminology
The UPS system and proteolysis are involved in the complex pathophysiology of hepatic cold I/R injury. Both are helpful for evaluating the fatty liver preservation using either static or dynamic preservation (with machine perfusion) strategies.
Peer-review
The manuscript is about Relevance of proteolysis and proteasome activation in fatty liver graft preservation. There must be possible prospective achievement in this basic studies. The authors try to solve the problem of preservation of fatty donor liver from ischemic injury in liver transplantation, and the study design was reasonable. The results were also good and provided some scientific hints.
